Clinical Trials
7
Active:1
Completed:1
Trial Phases
3 Phases
Phase 1:3
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (50.0%)Phase 3
2 (33.3%)Phase 2
1 (16.7%)A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of of VSA012 in Subjects with Paroxysmal Nocturnal Hemoglobinuria(PNH)
Not yet recruiting
- Conditions
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- First Posted Date
- 2025-02-27
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Visirna Therapeutics HK Limited
- Target Recruit Count
- 16
- Registration Number
- NCT06848296
A Phase I Clinical Study of VSA012 in Healthy Volunteers
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Visirna Therapeutics HK Limited
- Target Recruit Count
- 32
- Registration Number
- NCT06766929
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH Patients
Phase 3
Not yet recruiting
- Conditions
- Homozygous Familial Hypercholesterolemia (HoFH)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-02
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Visirna Therapeutics HK Limited
- Target Recruit Count
- 45
- Registration Number
- NCT06712771
A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Visirna Therapeutics HK Limited
- Target Recruit Count
- 45
- Registration Number
- NCT06322628
A Phase 3 Study of VSA001 in Chinese Adults with Familial Chylomicronemia Syndrome
Phase 3
Active, not recruiting
- Conditions
- Familial Chylomicronemia Syndrome
- Interventions
- Drug: PlaceboDrug: VSA001 injection
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Visirna Therapeutics HK Limited
- Target Recruit Count
- 30
- Registration Number
- NCT05902598
- Locations
- 🇨🇳
Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China
- Prev
- 1
- 2
- Next
News
No news found